(Q34273807)

1 August 2017

title

A multifaceted role for apoE in the clearance of beta-amyloid across the blood-brain barrier (English)

1 reference

1 August 2017

1 reference

Michael Mullan

5

0 references

author name string

Corbin Bachmeier

1

1 reference

1 August 2017

Daniel Paris

2

1 reference

1 August 2017

David Beaulieu-Abdelahad

3

1 reference

1 August 2017

Benoit Mouzon

4

1 reference

1 August 2017

Fiona Crawford

6

1 reference

1 August 2017

publication date

8 May 2012

1 reference

Neurodegenerative Diseases

1 August 2017

published in

1 reference

1 August 2017

volume

11

1 reference

1 August 2017

issue

1

1 reference

1 August 2017

page(s)

13-21

1 reference

Strategies for disease modification in Alzheimer's disease

1 August 2017

cites work

1 reference

Alzheimer's disease: strategies for disease modification

21 January 2018

1 reference

Intracellular amyloid-beta in Alzheimer's disease

21 January 2018

1 reference

Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease

21 January 2018

1 reference

Amyloid imaging in Alzheimer's disease.

21 January 2018

1 reference

Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier

21 January 2018

1 reference

RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain

21 January 2018

1 reference

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

21 January 2018

1 reference

Decreased clearance of CNS beta-amyloid in Alzheimer's disease

21 January 2018

1 reference

Understanding the basis for the association of apoE4 with Alzheimer's disease: opening the door for therapeutic approaches

21 January 2018

1 reference

The role of apolipoprotein E in Alzheimer's disease

21 January 2018

1 reference

Cerebral clearance of human amyloid-beta peptide (1-40) across the blood-brain barrier is reduced by self-aggregation and formation of low-density lipoprotein receptor-related protein-1 ligand complexes

21 January 2018

1 reference

Apolipoprotein E alters the processing of the beta-amyloid precursor protein in APP(V717F) transgenic mice

21 January 2018

1 reference

ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo

21 January 2018

1 reference

apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain

21 January 2018

1 reference

Characterization and use of human brain microvascular endothelial cells to examine β-amyloid exchange in the blood-brain barrier

21 January 2018

1 reference

Human apolipoprotein E2, E3, and E4 isoform-specific transgenic mice: human-like pattern of glial and neuronal immunoreactivity in central nervous system not observed in wild-type mice.

21 January 2018

1 reference

Selective antihypertensive dihydropyridines lower Aβ accumulation by targeting both the production and the clearance of Aβ across the blood-brain barrier

21 January 2018

1 reference

Anti-angiogenic activity of the mutant Dutch A(beta) peptide on human brain microvascular endothelial cells

21 January 2018

1 reference

Statins inhibit A beta-neurotoxicity in vitro and A beta-induced vasoconstriction and inflammation in rat aortae

21 January 2018

1 reference

Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E.

21 January 2018

1 reference

Apolipoprotein E (apoE) levels in brains from Alzheimer disease patients and controls.

21 January 2018

1 reference

Clearance of amyloid-beta by circulating lipoprotein receptors

21 January 2018

1 reference

The roles of receptor-associated protein (RAP) as a molecular chaperone for members of the LDL receptor family

21 January 2018

1 reference

Receptor-associated protein: a specialized chaperone and antagonist for members of the LDL receptor gene family

21 January 2018

1 reference

A dual role for apolipoprotein e in neuroinflammation: anti- and pro-inflammatory activity

21 January 2018

1 reference

Apolipoprotein E and beta-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependent

21 January 2018

1 reference

Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels

21 January 2018

1 reference

Apolipoprotein E, amyloid-beta, and blood-brain barrier permeability in Alzheimer disease

21 January 2018

1 reference

Radioimmunoassay studies of human apolipoprotein E.

21 January 2018

1 reference

The effect of apoE genotype and sex on ApoE plasma concentration is determined by dietary fat in healthy subjects.

21 January 2018

1 reference

Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid beta peptides

21 January 2018

1 reference

Human APOE isoform-dependent effects on brain beta-amyloid levels in PDAPP transgenic mice.

21 January 2018

1 reference

Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease

21 January 2018

1 reference

Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease

21 January 2018

1 reference

APOE polymorphism and clinical duration determine regional neuropathology in Swedish APP(670, 671) mutation carriers: implications for late-onset Alzheimer's disease.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000337231

1 reference

1 August 2017

1 reference